Mainstream

AbCellera signals clinical-stage transition with first patient dosing for ABCL635 and targets mid-2026 data milestone

AbCellera signals clinical-stage transition with first patient dosing for ABCL635 and targets mid-2026 data milestone

Post ContentabclRead More

You might also be interested in reading Oil falls, Bitcoin jumps to $72K, but is this BTC price breakout for real?.

August 7, 2025
In Mainstream